Author

V. C. T. M. Picece

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2

Frequent Co-Authors

A. E. Powell· 2 shared B. S. Ou· 2 shared E. Appel· 2 shared E. C. Gale· 2 shared J. Yan· 2 shared A. I. d'Aquino· 1 shared A. K. Grosskopf· 1 shared A. Nejatfard· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. E. Powell

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintJan 2, 2023

Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines

B. S. Ou, J. Baillet, V. C. T. M. Picece…·E. Appel

This paper develops CpG nanoparticle adjuvants that enhance the potency, durability, and breadth of COVID-19 vaccines by improving antigen delivery and immune response.

DOI 10.1101/2023.01.02.522505

experimental assaydrug response / drug discovery

𝕏 PostBluesky

BioengineeringAdvanced MaterialsPeer-reviewedOct 14, 2021

Hydrogel-based slow release of a receptor-binding domain subunit vaccine elicits neutralizing antibody responses against SARS-CoV-2

E. C. Gale, A. E. Powell, G. A. Roth…·E. Appel

This study shows that slow release of an RBD subunit vaccine via hydrogel enhances neutralizing antibody responses against SARS-CoV-2 compared to bolus administration.

DOI 10.1002/adma.202104362

experimental assaydrug response / drug discovery

𝕏 PostBluesky